The Times Australia
Google AI
News From Asia

.

Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No.

8 global ranking by both Ukraine and Bulgaria countries. This prestigious recognition underscores Takeda's commitment to creating a workplace that embraces diversity, equity and inclusion (DE&I), fostering an empowering culture across all locations it operates. This accolade reflects Takeda's consistent focus on employee well-being, trust-based leadership, and a people-centered approach to business.

At Takeda, we are committed to delivering an exceptional employee experience by cultivating an inclusive, purpose-driven workplace where our people can grow both personally and professionally. Being recognized as a Best Place to Work reflects our unwavering dedication to building a culture where every colleague feels valued, supported, and empowered to thrive.

Volodymyr Pedko, General Manager of Takeda Ukraine, shared:
"It gives me great pride to receive this recognition during such challenging times! It stands as a testament to the exceptional quality of work and everyone's commitment to building and sustaining an innovative and inclusive workplace in our organization."

Todor Kesimov, General Manager of Takeda Romania & Bulgaria, commented:
"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms our efforts to build a culture of trust, care, and respect in every country, including Bulgaria. This recognition inspires us to continue building a better future – for our employees, for patients, and for society."
Hashtag: #BestPlacesToWork


The issuer is solely responsible for the content of this announcement.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit .

For more information, please visit the program website: .

Times Magazine

AI is failing ‘Humanity’s Last Exam’. So what does that mean for machine intelligence?

How do you translate ancient Palmyrene script from a Roman tombstone? How many paired tendons ...

Does Cloud Accounting Provide Adequate Security for Australian Businesses?

Today, many Australian businesses rely on cloud accounting platforms to manage their finances. Bec...

Freak Weather Spikes ‘Allergic Disease’ and Eczema As Temperatures Dip

“Allergic disease” and eczema cases are spiking due to the current freak weather as the Bureau o...

IPECS Phone System in 2026: The Future of Smart Business Communication

By 2026, business communication is no longer just about making and receiving calls. It’s about speed...

With Nvidia’s second-best AI chips headed for China, the US shifts priorities from security to trade

This week, US President Donald Trump approved previously banned exports[1] of Nvidia’s powerful ...

Navman MiVue™ True 4K PRO Surround honest review

If you drive a car, you should have a dashcam. Need convincing? All I ask that you do is search fo...

The Times Features

The Week That Was in Federal Parliament Politics: Will We Have an Effective Opposition Soon?

Federal Parliament returned this week to a familiar rhythm: government ministers defending the p...

Why Pictures Help To Add Colour & Life To The Inside Of Your Australian Property

Many Australian homeowners complain that their home is still missing something, even though they hav...

What the RBA wants Australians to do next to fight inflation – or risk more rate hikes

When the Reserve Bank of Australia (RBA) board voted unanimously[1] to lift the cash rate to 3.8...

Do You Need a Building & Pest Inspection for New Homes in Melbourne?

Many buyers assume that a brand-new home does not need an inspection. After all, everything is new...

A Step-by-Step Guide to Planning Your Office Move in Perth

Planning an office relocation can be a complex task, especially when business operations need to con...

What’s behind the surge in the price of gold and silver?

Gold and silver don’t usually move like meme stocks. They grind. They trend. They react to inflati...

State of Play: Nationals vs Liberals

The State of Play with the National Party and How Things Stand with the Liberal Party Australia’s...

SMEs face growing payroll challenges one year in on wage theft reforms

A year after wage theft reforms came into effect, Australian SMEs are confronting a new reality. P...

Evil Ray declares war on the sun

Australians love the sun. The sun doesn't love them back. Melanoma takes over 1,300 Australian liv...